InvestorsHub Logo

dogn

09/01/22 7:25 AM

#387891 RE: CaptBeer #387890

AMRN collaboration with Mochida (PR’d by both companies in 2018) was to develop MND-2119 (revealed in Mochida PR as noted in my prior posts), so quite sure they have exclusive license.

CaptBeer

09/01/22 7:56 AM

#387895 RE: CaptBeer #387890

I just answered my own question:

Among other terms in the agreement, Amarin obtained an exclusive license to certain Mochida intellectual property to advance Amarin’s interests in the United States and certain other territories and the parties will collaborate to research and develop new products and indications based on EPA for Amarin’s commercialization in the United States and certain other territories. The potential new product and indication opportunities contemplated under this agreement are in relatively early stages of development.